Search Results - Kausik K. Ray FESC

Evolocumab is Initiated in Central and Eastern Europe at Much Higher LDL-C Levels Than Recommended in Guidelines: Results from the Observational HEYMANS Study by Vladimír Blaha MUDr, CSc, Roman Margoczy MUDr, Ivo Petrov MD, Arman Postadzhiyan MD, PhD, FESC, FACC, Katarína Rašlová MUDr, CSc, Hana Rosolová MUDr, DrSc, Ian Bridges MSc, Nafeesa N. Dhalwani PhD, Marie Zachlederova PhD, Kausik K. Ray FESC

Connect to this object online.